Epigenetics in gastric cancer: Challenges for clinical implications

Annals of Surgical Oncology

Volumn 16, Issue 7, 2009, Pages 2077-2078

  Ziogas, D ^a   Roukos, D ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BRCA1 PROTEIN; CARCINOGEN; DNA; HISTONE; MICRORNA; PROTEIN MLH1;

ANGIOGENESIS; APOPTOSIS; CANCER CELL; CANCER CLASSIFICATION; CANCER RISK; CELL INTERACTION; CLINICAL INDICATOR; CPG ISLAND; DISEASE COURSE; DNA METHYLATION; DNA REPAIR; DRUG TARGETING; EPIGENETICS; GENE EXPRESSION PROFILING; GENE SILENCING; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MICROARRAY ANALYSIS; ONCOGENE; PHYLOGENETIC TREE; PROGNOSIS; PROMOTER REGION; PROTEIN MODIFICATION; STOMACH CANCER; TUMOR BIOPSY; TUMOR SUPPRESSOR GENE;

CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; HUMANS; PROGNOSIS; STOMACH NEOPLASMS;

EID: 67649233102     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0472-y     Document Type: Letter

References (14)

1. Esteller M. Epigenetics in Cancer. N Engl J Med. 2008;358: 1148-59.
2. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med. 2003;349: 2042-54.
3. Esteller M, Silva JM, Dominguez G, et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst. 2000;92:564-9.
4. Roukos DH. Innovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies. Expert Rev Mol Diagn. 2008;8(1):29-39.
5. Park YS, Jin MY, Kim YJ, Yook JH, Kim BS, Jang SJ. The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma. Ann Surg Oncol. 2008;15(7):1968-76.
6. Saito Y, Liang G, Egger G, et al. Specific activation of microRNA- 127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell. 2006;9:435-43.
7. Lujambio A, Ropero S, Ballestar E, et al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res. 2007;67:1424-9 (Erratum).
8. Manolio TA, Brooks LD, Collins FS. A HapMap harvest of insights into the genetics of common disease. J Clin Invest. 2008; 118:1590-605.
9. Roukos DH. Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery. Expert Rev Mol Diagn. 2008;8(5):587-97.
10. Roukos DH. 21-gene assay: Challenges and promises in translating personal genomics and whole genome scans into personalized treatment of breast cancer. J Clin Oncol. 2009;27(8):1337-8.
11. Roukos DH, Lykoudis E, Liakakos T. Genomics and challenges toward personalized breast cancer local control. J ClinOncol. 2008; 26(26):4360-1.
12. My genome. So, what? Nature. 2008;456(7218):1 (editorial).
13. Ley TJ, Mardis ER, Ding L, et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature. 2008;456(7218):66-72.
14. Roukos DH. Assessing genetic variations-SNPs/CNVs-and interactions with environment for personalized gastric cancer prevention: Can personal genomics challenges be overcome? Expert Rev Mol Diagn. 2009;9(1):1-6.